Extreme bipolar androgen therapy with darolutamide and testosterone cypionate in patients with metastatic castration-resistant prostate cancer: ExBAT (LACOG 0620) trial.

Authors :: Isaacsson Velho, Pedro H
Girardi, Daniel da Motta
Soares, Andrey
Fontes Jardim, Denis Leonardo
Maluf, Fernando Cotait
Morbeck, Igor Alexandre
Dias, Mariane Fontes
Souza, Vinicius Carrera
Silva, Adriano Goncalves E
de Jesus, Rafaela Gomes
Rebelatto, Taiane Francieli
Bastos, Diogo Assed
Source :: Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, pTPS276-TPS276, 1p
Publication Year :: 2023

Full Text Access

Tools